{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T14:59:32Z","timestamp":1780066772961,"version":"3.54.0"},"reference-count":40,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T00:00:00Z","timestamp":1618876800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>It is difficult to differentiate between Parkinson's disease and multiple system atrophy parkinsonian subtype (MSA-P) because of the overlap of their signs and symptoms. Enormous efforts have been made to develop positron emission tomography (PET) imaging to differentiate these diseases. This study aimed to investigate the co-registration analysis of <jats:sup>18<\/jats:sup>F-fluorodopa and <jats:sup>18<\/jats:sup>F-flurodeoxyglucose PET images to visualize the difference between Parkinson's disease and MSA-P. We enrolled 29 Parkinson's disease patients, 28 MSA-P patients, and 10 healthy controls, who underwent both <jats:sup>18<\/jats:sup>F-fluorodopa and <jats:sup>18<\/jats:sup>F-flurodeoxyglucose PET scans. Patients with Parkinson's disease and MSA-P exhibited reduced bilateral striatal <jats:sup>18<\/jats:sup>F-fluorodopa uptake (<jats:italic>p<\/jats:italic> &amp;lt; 0.05, vs. healthy controls). Both regional specific uptake ratio analysis and statistical parametric mapping analysis of <jats:sup>18<\/jats:sup>F-flurodeoxyglucose PET revealed hypometabolism in the bilateral putamen of MSA-P patients and hypermetabolism in the bilateral putamen of Parkinson's disease patients. There was a significant positive correlation between <jats:sup>18<\/jats:sup>F-flurodeoxyglucose uptake and <jats:sup>18<\/jats:sup>F-fluorodopa uptake in the contralateral posterior putamen of MSA-P patients (<jats:italic>r<\/jats:italic>s = 0.558, <jats:italic>p<\/jats:italic> = 0.002). Both <jats:sup>18<\/jats:sup>F-flurodeoxyglucose and <jats:sup>18<\/jats:sup>F-fluorodopa PET images showed that the striatum was rabbit-shaped in the healthy control group segmentation analysis. A defective rabbit-shaped striatum was observed in the <jats:sup>18<\/jats:sup>F-fluorodopa PET image of patients with Parkinson's disease and MSA-P. In the segmentation analysis of <jats:sup>18<\/jats:sup>F-flurodeoxyglucose PET image, an intact rabbit-shaped striatum was observed in Parkinson's disease patients, whereas a defective rabbit-shaped striatum was observed in MSA-P patients. These findings suggest that there were significant differences in the co-registration analysis of <jats:sup>18<\/jats:sup>F-flurodeoxyglucose and <jats:sup>18<\/jats:sup>F-fluorodopa PET images, which could be used in the individual analysis to differentiate Parkinson's disease from MSA-P.<\/jats:p>","DOI":"10.3389\/fnagi.2021.648531","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T04:33:06Z","timestamp":1618893186000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Co-registration Analysis of Fluorodopa and Fluorodeoxyglucose Positron Emission Tomography for Differentiating Multiple System Atrophy Parkinsonism Type From Parkinson's Disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Wen-biao","family":"Xian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-chong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gan-hua","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-song","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Pei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e220","DOI":"10.1097\/RLU.0000000000000315","article-title":"Brain 18F-FDG PET imaging in the differential diagnosis of parkinsonism","volume":"39","author":"Akdemir","year":"2014","journal-title":"Clin. Nucl. Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/S0079-6123(08)62678-3","article-title":"Basal ganglia-thalamocortical circuits: parallel substrates for motor, oculomotor, \u201cprefrontal\u201d and \u201climbic\u201d functions","volume":"85","author":"Alexander","year":"1990","journal-title":"Prog. Brain Res"},{"key":"B3","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson Disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1136\/jnnp.57.3.278","article-title":"Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data","volume":"57","author":"Burn","year":"1994","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s00259-005-1904-y","article-title":"Comparison of FP-CIT SPECT with F-DOPA PET in patients with de novo and advanced Parkinson's disease","volume":"33","author":"Eshuis","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1212\/01.wnl.0000324625.00404.15","article-title":"Second consensus statement on the diagnosis of multiple system atrophy","volume":"71","author":"Gilman","year":"2008","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3575","DOI":"10.1002\/hbm.22863","article-title":"Dopaminergic correlates of metabolic network activity in Parkinson's disease","volume":"36","author":"Holtbernd","year":"2015","journal-title":"Hum. Brain Mapp"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1002\/mds.10261","article-title":"An imaging study of parkinsonism among African-Caribbean and Indian London communities","volume":"17","author":"Hu","year":"2002","journal-title":"Mov. Disord"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/brain\/awm086","article-title":"Changes in network activity with the progression of Parkinson's disease","volume":"130","author":"Huang","year":"2007","journal-title":"Brain"},{"key":"B10","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/brain\/awf080","article-title":"The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service","volume":"125","author":"Hughes","year":"2002","journal-title":"Brain"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1002\/mds.26052","article-title":"Neuropathology of multiple system atrophy: new thoughts about pathogenesis","volume":"29","author":"Jellinger","year":"2014","journal-title":"Mov. Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1136\/jnnp-2019-322588","article-title":"Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical parkinsonism","volume":"91","author":"Jiang","year":"2020","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00702-019-02012-0","article-title":"Dyskinesia in multiple system atrophy and progressive supranuclear palsy","volume":"126","author":"Jost","year":"2019","journal-title":"J. Neural. Transm."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.2967\/jnumed.119.227140","article-title":"presynaptic striatal dopaminergic function in atypical Parkinsonism: a metaanalysis of imaging studies","volume":"60","author":"Kaasinen","year":"2019","journal-title":"J. Nucl. Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1177\/0271678X16637880","article-title":"Metabolic network expression in parkinsonism: clinical and dopaminergic correlations","volume":"37","author":"Ko","year":"2017","journal-title":"J. Cereb. Blood. Flow. Metab"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1093\/cercor\/bhx267","article-title":"Network structure and function in Parkinson's disease. Cereb","volume":"28","author":"Ko","year":"2018","journal-title":"Cortex"},{"key":"B17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1136\/jnnp-2017-315813","article-title":"Recent advances in neuropathology, biomarkers and therapeutic approach of multiple system atrophy","volume":"89","author":"Koga","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.dadm.2019.04.002","article-title":"Factors affecting the harmonization of disease-related metabolic brain pattern expression quantification in [18F]FDG-PET (PETMETPAT)","volume":"11","author":"Kogan","year":"2019","journal-title":"Alzheimers Dement (Amst)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1001\/archneur.1997.00550200007003","article-title":"What is the accuracy of the clinical diagnosis of multiple system atrophy? A clinicopathologic study","volume":"54","author":"Litvan","year":"1997","journal-title":"Arch. Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/sj.jcbfm.9600358","article-title":"Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility","volume":"27","author":"Ma","year":"2007","journal-title":"J. Cereb. Blood Flow Metab"},{"key":"B21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nicl.2018.08.006","article-title":"FDG PET Parkinson's disease-related pattern as a biomarker for clinical trials in early stage disease","volume":"20","author":"Matthews","year":"2018","journal-title":"Neuroimage Clin"},{"key":"B22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00259-019-04570-7","article-title":"Abnormal pattern of brain glucose metabolism in Parkinson's disease: replication in three European cohorts","volume":"47","author":"Meles","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1093\/brain\/awh303","article-title":"The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations","volume":"127","author":"Ozawa","year":"2004","journal-title":"Brain"},{"key":"B24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-C","article-title":"Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop","volume":"20","author":"Parent","year":"1995","journal-title":"Brain Res. Brain Res. Rev"},{"key":"B25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/mds.24000","article-title":"Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy","volume":"27","author":"Perju-Dumbrava","year":"2012","journal-title":"Mov. Disord"},{"key":"B26","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.1468-1331.9.s3.3.x","article-title":"The differential diagnosis of Parkinson's disease","volume":"9","author":"Poewe","year":"2002","journal-title":"Eur. J. Neurol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord"},{"key":"B28","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1017\/S0317167100031814","article-title":"Accuracy of clinical diagnosis in parkinsonism\u2013a prospective study","volume":"18","author":"Rajput","year":"1991","journal-title":"Can. J. Neurol. Sci"},{"key":"B29","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/BF02251225","article-title":"Striatal [18F]fluorodopa utilization after COMT inhibition with entacapone studied with PET in advanced Parkinson's disease","volume":"10","author":"Ruottinen","year":"1995","journal-title":"J. Neural. Transm. Park. Dis. Dement Sect"},{"key":"B30","doi-asserted-by":"publisher","first-page":"572976","DOI":"10.3389\/fneur.2020.572976","article-title":"Neuroimaging advances in Parkinson's disease and atypical Parkinsonian syndromes","volume":"11","author":"Saeed","year":"2020","journal-title":"Front. Neurol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3389\/fnagi.2019.00249","article-title":"PET imaging of astrogliosis and tau facilitates diagnosis of Parkinsonian syndromes","volume":"11","author":"Sch\u00f6necker","year":"2019","journal-title":"Front. Aging Neurosci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/RLU.0000000000002664","article-title":"Decreased striatal vesicular monoamine transporter type 2 correlates with the nonmotor symptoms in Parkinson disease","volume":"44","author":"Shi","year":"2019","journal-title":"Clin. Nucl. Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1093\/brain\/awz034","article-title":"Dopamine depletion alters macroscopic network dynamics in Parkinson's disease","volume":"142","author":"Shine","year":"2019","journal-title":"Brain"},{"key":"B34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1002\/ana.25824","article-title":"Alpha-synuclein oligomers and neurofilament light chain in spinal fluid differentiate multiple system atrophy from lewy body synucleinopathies","volume":"88","author":"Singer","year":"2020","journal-title":"Ann. Neurol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0022-510X(02)00151-X","article-title":"Cerebral metabolic changes in early multiple system atrophy: a PET study","volume":"200","author":"Taniwaki","year":"2002","journal-title":"J. Neurol. Sci"},{"key":"B36","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00234-012-1132-7","article-title":"Differential diagnosis of parkinsonian syndromes using F-18 fluorodeoxyglucose positron emission tomography","volume":"55","author":"Tripathi","year":"2013","journal-title":"Neuroradiology"},{"key":"B37","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.neulet.2014.10.046","article-title":"The utility of susceptibility-weighted imaging for differentiating Parkinsonism-predominant multiple system atrophy from Parkinson's disease: correlation with 18F-flurodeoxyglucose positron-emission tomography","volume":"584","author":"Yoon","year":"2015","journal-title":"Neurosci. Lett"},{"key":"B38","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/j.1440-1789.2007.00841.x","article-title":"Multiple system atrophy: alpha-synuclein and neuronal degeneration","volume":"27","author":"Yoshida","year":"2007","journal-title":"Neuropathology"},{"key":"B39","doi-asserted-by":"publisher","first-page":"S60","DOI":"10.1016\/S1353-8020(11)70020-7","article-title":"18F-FDG PET study on the idiopathic Parkinson's disease from several parkinsonian-plus syndromes","volume":"18","author":"Zhao","year":"2012","journal-title":"Park. Relat. Disord"},{"key":"B40","doi-asserted-by":"publisher","first-page":"e01827","DOI":"10.1002\/brb3.1827","article-title":"Clinical features, MRI, and 18F-FDG-PET in differential diagnosis of Parkinson disease from multiple system atrophy","volume":"10","author":"Zhao","year":"2020","journal-title":"Brain Behav"}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.648531\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T04:33:08Z","timestamp":1618893188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2021.648531\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,20]]},"references-count":40,"alternative-id":["10.3389\/fnagi.2021.648531"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2021.648531","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,20]]},"article-number":"648531"}}